Glucagonoma syndrome: In vitro evidence that glucagon increases epidermal arachidonic acid

Larry L. Peterson, James C. Shaw, Karen M. Acott, Paul A. Mueggler, Frank Parker

Research output: Contribution to journalArticle

53 Citations (Scopus)

Abstract

A 63-year-old white woman with perioral dermatitis, a sore tongue, and an erythematous dermatosis in the inframammary and perineal regions underwent surgical removal of a pancreatic glucagonoma. The patient's plasma and pooled normal human plasma containing Sigma glucagon were fed to human keratinocyte cultures and increased arachidonic acid levels by 300% and 200%, respectively, when compared to pooled normal human plasma with no added commercial glucagon. These experiments suggest that glucagon may increase inflammatory mediators such as arachidonic acid and its metabolites in the epidermis, causing the skin lesions seen in the glucagonoma syndrome.

Original languageEnglish (US)
Pages (from-to)468-473
Number of pages6
JournalJournal of the American Academy of Dermatology
Volume11
Issue number3
DOIs
StatePublished - 1984

Fingerprint

Glucagonoma
Glucagon
Arachidonic Acid
Perioral Dermatitis
Keratinocytes
Tongue
Skin Diseases
Epidermis
Skin
In Vitro Techniques

ASJC Scopus subject areas

  • Dermatology

Cite this

Glucagonoma syndrome : In vitro evidence that glucagon increases epidermal arachidonic acid. / Peterson, Larry L.; Shaw, James C.; Acott, Karen M.; Mueggler, Paul A.; Parker, Frank.

In: Journal of the American Academy of Dermatology, Vol. 11, No. 3, 1984, p. 468-473.

Research output: Contribution to journalArticle

Peterson, Larry L. ; Shaw, James C. ; Acott, Karen M. ; Mueggler, Paul A. ; Parker, Frank. / Glucagonoma syndrome : In vitro evidence that glucagon increases epidermal arachidonic acid. In: Journal of the American Academy of Dermatology. 1984 ; Vol. 11, No. 3. pp. 468-473.
@article{27b311e9a4c14d9d887b228e187a7527,
title = "Glucagonoma syndrome: In vitro evidence that glucagon increases epidermal arachidonic acid",
abstract = "A 63-year-old white woman with perioral dermatitis, a sore tongue, and an erythematous dermatosis in the inframammary and perineal regions underwent surgical removal of a pancreatic glucagonoma. The patient's plasma and pooled normal human plasma containing Sigma glucagon were fed to human keratinocyte cultures and increased arachidonic acid levels by 300{\%} and 200{\%}, respectively, when compared to pooled normal human plasma with no added commercial glucagon. These experiments suggest that glucagon may increase inflammatory mediators such as arachidonic acid and its metabolites in the epidermis, causing the skin lesions seen in the glucagonoma syndrome.",
author = "Peterson, {Larry L.} and Shaw, {James C.} and Acott, {Karen M.} and Mueggler, {Paul A.} and Frank Parker",
year = "1984",
doi = "10.1016/S0190-9622(84)70192-7",
language = "English (US)",
volume = "11",
pages = "468--473",
journal = "Journal of the American Academy of Dermatology",
issn = "0190-9622",
publisher = "Mosby Inc.",
number = "3",

}

TY - JOUR

T1 - Glucagonoma syndrome

T2 - In vitro evidence that glucagon increases epidermal arachidonic acid

AU - Peterson, Larry L.

AU - Shaw, James C.

AU - Acott, Karen M.

AU - Mueggler, Paul A.

AU - Parker, Frank

PY - 1984

Y1 - 1984

N2 - A 63-year-old white woman with perioral dermatitis, a sore tongue, and an erythematous dermatosis in the inframammary and perineal regions underwent surgical removal of a pancreatic glucagonoma. The patient's plasma and pooled normal human plasma containing Sigma glucagon were fed to human keratinocyte cultures and increased arachidonic acid levels by 300% and 200%, respectively, when compared to pooled normal human plasma with no added commercial glucagon. These experiments suggest that glucagon may increase inflammatory mediators such as arachidonic acid and its metabolites in the epidermis, causing the skin lesions seen in the glucagonoma syndrome.

AB - A 63-year-old white woman with perioral dermatitis, a sore tongue, and an erythematous dermatosis in the inframammary and perineal regions underwent surgical removal of a pancreatic glucagonoma. The patient's plasma and pooled normal human plasma containing Sigma glucagon were fed to human keratinocyte cultures and increased arachidonic acid levels by 300% and 200%, respectively, when compared to pooled normal human plasma with no added commercial glucagon. These experiments suggest that glucagon may increase inflammatory mediators such as arachidonic acid and its metabolites in the epidermis, causing the skin lesions seen in the glucagonoma syndrome.

UR - http://www.scopus.com/inward/record.url?scp=0021165852&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021165852&partnerID=8YFLogxK

U2 - 10.1016/S0190-9622(84)70192-7

DO - 10.1016/S0190-9622(84)70192-7

M3 - Article

C2 - 6090515

AN - SCOPUS:0021165852

VL - 11

SP - 468

EP - 473

JO - Journal of the American Academy of Dermatology

JF - Journal of the American Academy of Dermatology

SN - 0190-9622

IS - 3

ER -